LCT Share Price

Open 0.10 Change Price %
High 0.12 1 Day 0.01 10.00
Low 0.10 1 Week 0.00 0.00
Close 0.11 1 Month 0.02 22.22
Volume 287501 1 Year 0.06 120.00
52 Week High 0.13
52 Week Low 0.05
LCT Important Levels
Resistance 2 0.13
Resistance 1 0.12
Pivot 0.11
Support 1 0.10
Support 2 0.09
ASX Australia Most Active Stocks
AGO 0.05 0.00%
AGO 0.05 0.00%
AGO 0.05 0.00%
VXR 0.01 0.00%
MOD 0.04 0.00%
MOD 0.04 0.00%
TLS 4.84 -0.21%
TLS 4.84 -0.21%
TLS 4.84 -0.21%
BUR 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
GBZ 0.02 100.00%
TMX 0.02 100.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
PYC 0.04 33.33%
GME 0.09 28.57%
GME 0.09 28.57%
More..
ASX Australia Top Losers Stocks
NSE 0.00 -100.00%
NSE 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
SER 0.01 -50.00%
SER 0.01 -50.00%
More..

Living Cell Technologies Ltd (ASX: LCT)

LCT Technical Analysis 4
As on 17th Feb 2017 LCT Share Price closed @ 0.11 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.08 & Buy for SHORT-TERM with Stoploss of 0.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
LCT Target for February
1st Target up-side 0.13
2nd Target up-side 0.15
3rd Target up-side 0.16
1st Target down-side 0.09
2nd Target down-side 0.07
3rd Target down-side 0.06
LCT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.lctglobal.com
LCT Address
LCT
Hunters Corner
PO Box 23566
Auckland, 2155
New Zealand
Phone: 64 9 276 2690
Fax: 64 9 276 2691
LCT Latest News
Investors are Looking at Levels for Living Cell Technologies Limited (LCT.AX)   Searcy News   - 14th Feb 17
BRIEF-Living Cell Technologies receives approval to commence treating patients ...   Reuters   - 08th Feb 17
Living Cell Technologies' patent application published in the US   Proactive Investors Australia   - 12th Jan 17
Living Cell Technologies making progress in Parkinson's treatment   Proactive Investors Australia   - 23rd Dec 16
Reversal Of Neurological Deterioration In Parkinson's Disease With NTCELL   Seeking Alpha   - 05th Dec 16
Living Cell Technologies Ltd in an ASX trading halt   Proactive Investors Australia   - 24th Nov 16
Living Cell Technologies Ltd advancing clinical trial for Parkinson's   Proactive Investors Australia   - 05th Oct 16
Demonstrates Continued Reversal of Parkinson's Disease   Business Wire (press release)   - 07th Jun 16
Clinical Study in Parkinson's Meets Endpoints   Business Wire (press release)   - 15th Jun 15
Andrew Patterson talks Andrea Grant at Living Cell Technologies, a company ...   Interest.co.nz   - 14th May 13
Interactive Technical Analysis Chart Living Cell Technologies Ltd ( LCT ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Living Cell Technologies Ltd
LCT Business Profile
Living Cell Technologies Limited, a cell implant company, develops living cell products for the treatment of diabetes and neurological diseases primarily in New Zealand. The company’s technology, IMMUPEL, coats cells with protective capsules that prevent them from attack by the patient’s immune system. Its product pipeline includes DIABECELL, a porcine insulin-producing cell product for the treatment of type 1 diabetes; and NTCELL, a choroid plexus cell product to treat Parkinson's disease and other disorders, such as stroke, Huntington's disease, and hearing loss, as well as wound hearing. Living Cell Technologies Limited was founded in 1987 and is based in Auckland, New Zealand.